Rchr
J-GLOBAL ID:200901038273837839   Update date: Jan. 30, 2024

Kikuta Atsushi

キクタ アツシ | Kikuta Atsushi
Affiliation and department:
Job title: Professor
Research field  (1): Hematology and oncology
Research theme for competitive and other funds  (4):
  • 2019 - 2022 The mechanisms of inducing anti-tumor cytotoxic T cells in the tumor immune microenvironment
  • 2016 - 2021 Building up a long-term follow-up system for patients with Pediatric, Adolescent, and Young Adult Thyroid Carcinoma
  • 2015 - 2018 Cancer vaccine with Th1 inducing DC through Notch ligand Dll4
  • 2007 - 2009 molecular analyses and translational research of neuroblastoma based upon a clinical trial of the nation-wide group study
Papers (5):
MISC (2):
  • Hiroyuki Fujisaki, Yoshiko Hashii, Keita Terashima, Hiroaki Goto, Keizo Horibe, Kazuhiko Sugiyama, Akinobu Watanabe, Saori Sugimoto, Takaaki Yanagisawa, Atsushi Kikuta, et al. PHASE 1/2 STUDY OF DSP-7888 IN PEDIATRIC PATIENTS WITH MALIGNANT GLIOMA. NEURO-ONCOLOGY. 2018. 20. 202-202
  • Chitose Ogawa, Atsushi Manabe, Hiroaki Goto, Katsuyoshi Koh, Daisuke Tomizawa, Keitaro Fukushima, Ken-ichiro Watanabe, Keizo Horibe, Atsushi Kikuta, Mitsuma Hamada, et al. Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase(R)) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). BLOOD. 2014. 124. 21
Lectures and oral presentations  (1):
  • Ex vivo-activated allogeneic CD4+ T-cells disrupt immunosuppressive tumor microenvironment, and induce host tumor-specific cytotoxic T-cells in mice
    (34th Annual Meeting & Pre-Conference Programs(SITC 2019), National Harbor, 2019)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page